[
  {
    "ts": null,
    "headline": "Here's Why You Should Retain INSP Stock in Your Portfolio for Now",
    "summary": "INSP navigates a product shift as Inspire V gains traction, reimbursement improves, and management balances growth with near-term pressures.",
    "url": "https://finnhub.io/api/news?id=c6668d96bd46f879366fca94f5f69ff47dd6ef9951629c0b3d7f5ccbb3b08ef7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769103120,
      "headline": "Here's Why You Should Retain INSP Stock in Your Portfolio for Now",
      "id": 138206939,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "INSP navigates a product shift as Inspire V gains traction, reimbursement improves, and management balances growth with near-term pressures.",
      "url": "https://finnhub.io/api/news?id=c6668d96bd46f879366fca94f5f69ff47dd6ef9951629c0b3d7f5ccbb3b08ef7"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (NYSE:BSX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?",
    "summary": "It is hard to get excited after looking at Boston Scientific's (NYSE:BSX) recent performance, when its stock has...",
    "url": "https://finnhub.io/api/news?id=cdbd1ce72f476f5559ba27e591a481860775ed6133638dc7c93beb7c29ec28bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769079655,
      "headline": "Boston Scientific Corporation (NYSE:BSX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?",
      "id": 138203183,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "It is hard to get excited after looking at Boston Scientific's (NYSE:BSX) recent performance, when its stock has...",
      "url": "https://finnhub.io/api/news?id=cdbd1ce72f476f5559ba27e591a481860775ed6133638dc7c93beb7c29ec28bf"
    }
  },
  {
    "ts": null,
    "headline": "Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio Activity",
    "summary": "Polen Global Growth Portfolio returned -2.5% in Q4 2025, lagging the MSCI ACWI Index. Read for analysis on new Tencent and Spotify stakes and Oracle's drag.",
    "url": "https://finnhub.io/api/news?id=f9d8ca6c87eace8e18246d42e14f450a2d105e718f02bd83c90e6aaf31b35272",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769040300,
      "headline": "Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio Activity",
      "id": 138201130,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345030566/image_1345030566.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Polen Global Growth Portfolio returned -2.5% in Q4 2025, lagging the MSCI ACWI Index. Read for analysis on new Tencent and Spotify stakes and Oracle's drag.",
      "url": "https://finnhub.io/api/news?id=f9d8ca6c87eace8e18246d42e14f450a2d105e718f02bd83c90e6aaf31b35272"
    }
  }
]